Try BioPharma’s Most Respected News Source for More than 20 Years

Aegerion Seeks $47.3M After FDA Accepts Lomitapide NDA Will U.S. Carry Weight on Global R&D Funding?  Earliest Immune Responder is Critical to Long-term Success  Amarantus Restart Makes Another Run at MANF Protein That’s not all, with BioWorld Today you'll get the inside track on: What your competitors are doing ... so you can easily identify opportunities and threats. Where the smart money is going … where top investors are placing their bets and who is raising funds. The latest technological innovations and discoveries … to clinical study results across the industry. What the FDA and Congress are up to … so you can prepare for coming changes and recent approvals. With writers and editors stationed around the globe, BioWorld Today provides the critical news and insights you need to be competitive in this industry! Access your free issue now!

Get Connected!   BioWorld | 3525 Piedmont Road, Building 6, Suite 400 | Atlanta, GA 30305

You have received this email because you registered at BioSpace. BioSpace regularly sends emails to active subscribers on behalf of our advertising partners or to promote our own products and services. If you would like to stop receiving all email communications from BioSpace, you can unsubscribe at any time by clicking here. BioSpace 6465 South Greenwood Plaza, Suite 400, Centennial, CO 80111, U.S. (888) BIOSPACE